The cost effectiveness of elective laparoscopic sigmoid resection for symptomatic diverticular disease: financial outcome of the randomized control Sigma trial.

MLA

Klarenbeek, Bastiaan R., et al. “The Cost Effectiveness of Elective Laparoscopic Sigmoid Resection for Symptomatic Diverticular Disease: Financial Outcome of the Randomized Control Sigma Trial.” Surgical Endoscopy & Other Interventional Techniques, vol. 25, no. 3, Mar. 2011, pp. 776–83. EBSCOhost, https://doi.org/10.1007/s00464-010-1252-2.

APA

Klarenbeek, B. R., Coupé, V. M. H., Peet, D. L. V. der, & Cuesta, M. A. (2011). The cost effectiveness of elective laparoscopic sigmoid resection for symptomatic diverticular disease: financial outcome of the randomized control Sigma trial. Surgical Endoscopy & Other Interventional Techniques, 25(3), 776–783. https://doi.org/10.1007/s00464-010-1252-2

Chicago

Klarenbeek, Bastiaan R., Veerle M. H. Coupé, Donald L. Van der Peet, and Miguel A. Cuesta. 2011. “The Cost Effectiveness of Elective Laparoscopic Sigmoid Resection for Symptomatic Diverticular Disease: Financial Outcome of the Randomized Control Sigma Trial.” Surgical Endoscopy & Other Interventional Techniques 25 (3): 776–83. doi:10.1007/s00464-010-1252-2.